Journal of Thrombosis and Thrombolysis

, Volume 28, Issue 2, pp 124–131 | Cite as

Effectiveness of a clinical decision support system to identify heparin induced thrombocytopenia

  • Jeffrey M. Riggio
  • Mandelin K. Cooper
  • Benjamin E. Leiby
  • Jeanine M. Walenga
  • Geno J. Merli
  • Jonathan E. Gottlieb


Background Subtle decreases in platelet count may impede timely recognition of heparin-induced thrombocytopenia (HIT), placing the patient at increased risk of thrombotic events. Objective A clinical decision support system (CDSS) was developed to alert physicians using computerized provider order entry when a patient with an active order for heparin experienced platelet count decreases consistent with HIT. Methods Comparisons for timeliness of HIT identification and treatment were evaluated for the year preceding and year following implementation of the CDSS in patients with laboratory confirmation of HIT. Results During the intervention time period, the CDSS alert occurred 41,922 times identifying 2,036 patients who had 2,338 inpatient admissions. The CDSS had no significant impact on time from fall in platelet count to HIT laboratory testing (control 2.3 days vs intervention 3.0 days P = 0.30) and therapy (control 19.3 days vs intervention 15.0 days P = 0.45), and appeared to delay discontinuation of heparin products (control 1.3 days vs. intervention 2.9 days P = 0.04). However, discontinuation of heparin following shorter exposure duration and after smaller decrease in platelet count occurred during the intervention period. The HIT CDSS sensitivity and specificity were each 87% with a negative predictive value of 99.9% and positive predictive value of 2.3%. Conclusions Implementation of a CDSS did not appear to improve the ability to detect and respond to potential HIT, but resulted in increased laboratory testing and changes in clinician reactions to decreasing platelet counts that deserve further study.


Heparin induced thrombocytopenia Clinical decision support system Computer alert Computerized provider order entry 


  1. 1.
    Warkentin TE (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535–555PubMedCrossRefGoogle Scholar
  2. 2.
    Girolami B, Prandoni P, Stefani PM et al (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood 101:2955–2959PubMedCrossRefGoogle Scholar
  3. 3.
    Spencer FA (2000) Heparin-induced thrombocytopenia patient profiles and clinical manifestations. J Thromb Thrombolysis 10:S21–S25CrossRefGoogle Scholar
  4. 4.
    Warkentin TE, Roberts RS, Hirsh J, Kelton JG (2003) An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 163:2518–2524PubMedCrossRefGoogle Scholar
  5. 5.
    Warkentin TE, Greinacher A (2004) Heparin induced thrombocytopenia: recognition, treatment and prevention: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:311S–337SPubMedCrossRefGoogle Scholar
  6. 6.
    Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344:1286–1292PubMedCrossRefGoogle Scholar
  7. 7.
    Warkentin TE, Levin MN, Hirsch J et al (1995) Heparin-induced thrombocytopenia with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330–1335PubMedCrossRefGoogle Scholar
  8. 8.
    Greinacher A, Warkentin TE (2006) Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update. Thromb Res 118:165–176PubMedCrossRefGoogle Scholar
  9. 9.
    Spinler SA, Dager W (2003) Overview of heparin-induced thrombocytopenia. Am J Health Syst Pharm 60:S5–S11PubMedGoogle Scholar
  10. 10.
    Walgenga JM, Jeske WP, Messmore HL (2000) Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis 10:S13–S20CrossRefGoogle Scholar
  11. 11.
    Spinler SA (2003) Managing heparin-induced thrombocytopenia: preventing life-and limb-threatening thrombosis. Am J Health Syst Pharm 60:S2–S4PubMedGoogle Scholar
  12. 12.
    Warkentin TE, Kelton JG (1996) A 14-year study of heparin-induced thrombocytopenia. Am J Med 101:502–507PubMedCrossRefGoogle Scholar
  13. 13.
    Bates DW, Gawande AA (2003) Improving safety with information technology. N Engl J Med 348:2526–2534PubMedCrossRefGoogle Scholar
  14. 14.
    Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran PF (1999) Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 106:629–635PubMedCrossRefGoogle Scholar
  15. 15.
    Fabris F, Luzzatto G, Soini B et al (2002) Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia. J Intern Med 252:149–154PubMedCrossRefGoogle Scholar
  16. 16.
    Warkentin TE (2002) Platelet count monitoring and laboratory testing for heparin-induced thrombocytopenia: recommendations of the college of American pathologists. Arch Pathol Lab Med 126:1415–1423PubMedGoogle Scholar
  17. 17.
    Arepally GM, Ortel TL (2006) Heparin-induced thrombocytopenia. N Engl J Med 355:809–817PubMedCrossRefGoogle Scholar
  18. 18.
    Classen DC (1998) Clinical decision support systems improve clinical practice and quality of care. JAMA 280:1360–1361PubMedCrossRefGoogle Scholar
  19. 19.
    Garg AX, Adhikari NK, McDonald et al (2005) Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 293:1223–1238PubMedCrossRefGoogle Scholar
  20. 20.
    Chaudhry B, Wang J, Wu S et al (2006) Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 144:742–752PubMedGoogle Scholar
  21. 21.
    Warkentin TE, Greinacher A, Koster A, Lincoff AM (2008) Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):340S–380SPubMedCrossRefGoogle Scholar
  22. 22.
    Van der Sijs H, Aarts J, Vulto A, Berg M (2006) Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 13(2):138–147PubMedCrossRefGoogle Scholar
  23. 23.
    Warkentin TE (2000) Heparin-induced thrombocytopenia and its treatment. J Thromb Thrombolysis 9:S29–S35PubMedCrossRefGoogle Scholar
  24. 24.
    Greinacher A, Eichler P, Lubenow N, Kwasny H, Luz M (2000) Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. Blood 96:846–851PubMedGoogle Scholar
  25. 25.
    Hunt DL, Haynes RB, Hanna SE, Smith K (1998) Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA 280:1339–1346PubMedCrossRefGoogle Scholar
  26. 26.
    Mosen D, Elliot CG, Egger MJ et al (2004) The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest 125:1635–1641PubMedCrossRefGoogle Scholar
  27. 27.
    Durieux P (2005) Electronic medical alerts—so simple, so complex. N Engl J Med 352:1034–1036PubMedCrossRefGoogle Scholar
  28. 28.
    Dexter PR, Perkins S, Overhage JM, Maharry K, Kohler RB, McDonald CJ (2001) A computerized reminder system to increase the use of preventative care for hospitalized patients. N Engl J Med 345:965–970PubMedCrossRefGoogle Scholar
  29. 29.
    Raschke RA, Gollihare B, Wunderlich TA et al (1998) A computer alert system to prevent injury from adverse drug events. JAMA 280:1317–1320PubMedCrossRefGoogle Scholar
  30. 30.
    Durieux P, Nizard R, Ravaud P, Mounier N, Lepage E (2000) A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 283:2816–2821PubMedCrossRefGoogle Scholar
  31. 31.
    Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin-induced thrombocytopenia: a critical review. Arch Intern Med 164:361–369PubMedCrossRefGoogle Scholar
  32. 32.
    Macdonald D, Bhalla P, Cass W et al (2002) Computerized management of oral anticoagulant therapy: experience in major joint arthroplasty. Can J Surg 45:47–52PubMedGoogle Scholar
  33. 33.
    Wilson JW, Oyen LJ, Ou NN et al (2005) Hospital rules-based system: the next generation of medical informatics for patient safety. Am J Health Syst Pharm 62:499–505PubMedCrossRefGoogle Scholar
  34. 34.
    Evans RS, Pestotnik SL, Classen DC et al (1998) A computer-assisted management program for antibiotics and other antiinfective agents. New Eng J Med 338:232–238PubMedCrossRefGoogle Scholar
  35. 35.
    Wachter RM (2006) Expected and unanticipated consequences of the quality and information technology revolutions. JAMA 295:2780–2783PubMedCrossRefGoogle Scholar
  36. 36.
    Kucher N, Koo S, Quiroz R et al (2005) Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 352:969–977PubMedCrossRefGoogle Scholar
  37. 37.
    Blumenthal D, Glaser JP (2007) Information technology comes to medicine. New Eng J Med 356:2527–2534PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Jeffrey M. Riggio
    • 1
  • Mandelin K. Cooper
    • 2
  • Benjamin E. Leiby
    • 3
  • Jeanine M. Walenga
    • 4
  • Geno J. Merli
    • 5
  • Jonathan E. Gottlieb
    • 6
  1. 1.Department of Medicine, Jefferson Internal Medicine AssociatesThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Department of PharmacyWesley Medical CenterWichitaUSA
  3. 3.Division of Biostatistics, Department of Pharmacology and Experimental TherapeuticsThomas Jefferson UniversityPhiladelphiaUSA
  4. 4.Department of Thoracic and Cardiovascular Surgery and Pathology, Cardiovascular InstituteLoyola University Medical CenterMaywoodUSA
  5. 5.Department of Medicine, Jefferson Center for Vascular DiseasesThomas Jefferson UniversityPhiladelphiaUSA
  6. 6.Department of Medicine, Barnes-Jewish HospitalWashington University School of MedicineSt. LouisUSA

Personalised recommendations